Literature DB >> 7276636

Interaction of Vibrio vulnificus with human polymorphonuclear leukocytes: association of virulence with resistance to phagocytosis.

A Kreger, L DeChatelet, P Shirley.   

Abstract

The results of studies described in this report support the ideas that virulence of Vibrio vulnificus is associated, at least in part, with resistance to phagocytosis and that the ability of the bacterium to resist phagocytosis results from its possession of an antiphagocytic surface antigen. These conclusions are based on the observations that (1) human polymorphonuclear leukocytes (PMNLs) exhibited a significantly weaker chemiluminescent response and phagocytic response when interacting with a virulent strain of the bacterium than when challenged with a weakly virulent strain of the bacterium; (2) rabbit antiserum to the virulent bacterium, but not normal rabbit serum, significantly enhanced the chemiluminescent response of PMNLs challenged with the virulent bacterium and significantly enhanced ingestion of the bacterium by the PMNLs; and (3) the opsonic activity of the antiserum was removed by adsorption with a formalin-killed, whole cell preparation of the virulent bacterium.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7276636     DOI: 10.1093/infdis/144.3.244

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  31 in total

1.  Genetic distinctions among clinical and environmental strains of Vibrio vulnificus.

Authors:  Maria Chatzidaki-Livanis; Michael A Hubbard; Katrina Gordon; Valerie J Harwood; Anita C Wright
Journal:  Appl Environ Microbiol       Date:  2006-09       Impact factor: 4.792

2.  Correlation between virulence and colony morphology in Vibrio vulnificus.

Authors:  L M Simpson; V K White; S F Zane; J D Oliver
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

3.  Pulsed-field gel electrophoresis and ribotype profiles of clinical and environmental Vibrio vulnificus isolates.

Authors:  M L Tamplin; J K Jackson; C Buchrieser; R L Murphree; K M Portier; V Gangar; L G Miller; C W Kaspar
Journal:  Appl Environ Microbiol       Date:  1996-10       Impact factor: 4.792

4.  The lipopolysaccharide O side chain of Vibrio vulnificus serogroup E is a virulence determinant for eels.

Authors:  C Amaro; B Fouz; E G Biosca; E Marco-Noales; R Collado
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

5.  Relation of capsular materials and colony opacity to virulence of Vibrio vulnificus.

Authors:  S Yoshida; M Ogawa; Y Mizuguchi
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

6.  Protection of mice against Vibrio vulnificus disease by vaccination with surface antigen preparations and anti-surface antigen antisera.

Authors:  A S Kreger; L D Gray; J Testa
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

7.  The extracellular cytolysin of Vibrio vulnificus: inactivation and relationship to virulence in mice.

Authors:  A C Wright; J G Morris
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

8.  Intraspecific Differentiation of Vibrio vulnificus Biotypes by Amplified Fragment Length Polymorphism and Ribotyping.

Authors:  C R Arias; L Verdonck; J Swings; E Garay; R Aznar
Journal:  Appl Environ Microbiol       Date:  1997-07       Impact factor: 4.792

9.  Wound infections caused by Vibrio vulnificus, a marine vibrio, in inland areas of the United States.

Authors:  C O Tacket; T J Barrett; J M Mann; M A Roberts; P A Blake
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

10.  Heterogeneity among isolates of Vibrio vulnificus recovered from eels (Anguilla anguilla) in Denmark.

Authors:  L Høi; I Dalsgaard; A DePaola; R J Siebeling; A Dalsgaard
Journal:  Appl Environ Microbiol       Date:  1998-12       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.